June 2-6, 2010 in Beijing.: 19th World Congress of IACAPAP and the 6th Congress of ASCAPAP

Dr Deepak Gupta: “Role of M-B12 Injections in children with Autistic Spectrum Disorders (ASD)” abstract was accepted for presentation.

DOAST treatment methodology-under "BIOMEDICAL INTERVENTIONS towards AUTISM" is accepted by Autism Society of America for their up coming 41st conference this July 2010. : Dr Karthikeyen Natarajan

Title of the paper "Decisive denominator and a biomedical intervention to ameliorate autism".

(Abstract ;- ‘Chronic inflammation’ could be the ‘common denominator’ for connectivity and processing abnormalities resulting in autism. Evidence suggests the GI tract as a potential organ system suffering ‘molecular disorder’ and ‘chronic inflammation’, consequently producing neuroglial inflammatory activity. Primarily targeted towards GI tract inflammation, ‘Integrated therapy’ restores ‘molecular order’. Improved behaviour and cognition of individuals thus treated lends credence to this common denominator as an autism treatment target. Consistent replication of the observed phenotypic data provides significant leads for further explorative research.)